Overexpression of tyrosine hydroxylase in dopaminergic neurons increased sensitivity to methamphetamine.
Addiction
Adeno-associated virus
Dopamine
Locomotor activity
Methamphetamine
Tyrosine hydroxylase
Journal
Neurochemistry international
ISSN: 1872-9754
Titre abrégé: Neurochem Int
Pays: England
ID NLM: 8006959
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
14
09
2022
revised:
20
01
2023
accepted:
24
01
2023
pubmed:
29
1
2023
medline:
15
3
2023
entrez:
28
1
2023
Statut:
ppublish
Résumé
Drug abuse is one of the great social problems in the world and a major healthcare challenge. It is supposed that sensitivity and reactivity to abuse drugs may vary from person to person, while its molecular basis is largely unknown. Dopaminergic neurons are deeply involved in addiction, and tyrosine hydroxylase (TH) catalyzes the first and rate-limiting step of the biosynthesis of dopamine (DA). We investigated the effects of increased TH expression on the metabolism of DA and reactivity to methamphetamine (METH), a drug of abuse, in mice. Wild-type TH (WT-TH) or the S40E mutant of TH (S40E-TH), which is an active form of TH mimicking phosphorylated TH at the 40th serine, was expressed in midbrain dopaminergic neurons using an adeno-associated virus (AAV) vector. The biochemical analysis showed that the turnover rates of DA in the nerve terminals were increased by the expression of WT-TH and S40E-TH, while there were few changes in the DA contents. Next, we administered METH to TH-overexpressing mice. We found that the S40E-TH-expressing mice responded to lower doses of METH than the control mice and WT-TH mice. The stereotyped behaviors appeared first in S40E-TH mice and then in WT-TH and control mice in this order. These data showed that the TH activity and expression level differentially affect DA metabolism in the nerve terminals from that in the cell bodies and that the TH activity and expression level are one of the determining factors for sensitivity and reactivity to METH. We suggest that TH may be a drug target for ameliorating sensitivity to drugs of abuse.
Identifiants
pubmed: 36709046
pii: S0197-0186(23)00019-0
doi: 10.1016/j.neuint.2023.105491
pii:
doi:
Substances chimiques
Methamphetamine
44RAL3456C
Tyrosine 3-Monooxygenase
EC 1.14.16.2
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
105491Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest S.M. owns equity in a gene therapy company (Gene Therapy Research Institution, Co., Ltd.) that commercializes the use of AAV vectors for gene therapy applications. To the extent that the work in this manuscript increases the value of these commercial holdings, there is a conflict of interest. The other authors of this manuscript have no conflicts of interest.